Prospera Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.08M Sell
71,841
-1,136
-2% -$150K 0.13% 170
2026
Q1
$10.2M Sell
72,977
-9,668
-12% -$1.35M 0.16% 140
2025
Q4
$10.1M Buy
82,645
+5,657
+7% +$687K 0.17% 135
2025
Q3
$8.55M Buy
76,988
+1,499
+2% +$170K 0.15% 152
2025
Q2
$8.37M Sell
75,489
-48,505
-39% -$5.16M 0.16% 141
2025
Q1
$13.9M Buy
123,994
+34,329
+38% +$3.54M 0.32% 71
2024
Q4
$8.28M Buy
89,665
+11,050
+14% +$995K 0.19% 121
2024
Q3
$6.59M Buy
78,615
+16,678
+27% +$1.27M 0.17% 131
2024
Q2
$4.25M Buy
61,937
+8,576
+16% +$572K 0.12% 189
2024
Q1
$3.91M Buy
53,361
+5,415
+11% +$416K 0.12% 192
2023
Q4
$3.88M Buy
47,946
+3,569
+8% +$278K 0.13% 182
2023
Q3
$3.33M Buy
44,377
+1,309
+3% +$101K 0.13% 178
2023
Q2
$3.32M Buy
43,068
+3,723
+9% +$297K 0.13% 187
2023
Q1
$3.26M Buy
39,345
+3,125
+9% +$259K 0.13% 189
2022
Q4
$3.11M Sell
36,220
-6,599
-15% -$523K 0.16% 156
2022
Q3
$2.64M Buy
42,819
+549
+1% +$34.6K 0.14% 187
2022
Q2
$2.61M Buy
42,270
+2,268
+6% +$140K 0.13% 194
2022
Q1
$2.38M Buy
40,002
+14,897
+59% +$952K 0.1% 242
2021
Q4
$1.82M Sell
25,105
-6,512
-21% -$449K 0.08% 285
2021
Q3
$2.21M Buy
31,617
+10,763
+52% +$756K 0.11% 227
2021
Q2
$1.44M Sell
20,854
-323
-2% -$21.6K 0.07% 310
2021
Q1
$1.37M Buy
21,177
+2,118
+11% +$137K 0.08% 283
2020
Q4
$1.11M Buy
19,059
+18,327
+2,504% +$1.11M 0.08% 271
2020
Q3
$46K Sell
732
-15,656
-96% -$1.09M 0.02% 647
2020
Q2
$1.26M Sell
16,388
-48,504
-75% -$3.72M 0.11% 208
2020
Q1
$4.85M Buy
64,892
+49,667
+326% +$3.43M 0.51% 32
2019
Q4
$989K Buy
15,225
+2,610
+21% +$170K 0.08% 263
2019
Q3
$800K Sell
12,615
-457
-3% -$29.9K 0.08% 211
2019
Q2
$892K Buy
13,072
+4,519
+53% +$297K 0.1% 175
2019
Q1
$574K Buy
8,553
+2,342
+38% +$156K 0.19% 147
2018
Q4
$409K Buy
6,211
+2,264
+57% +$158K 0.08% 232
2018
Q3
$300K Sell
3,947
-789
-17% -$59.6K 0.06% 310
2018
Q2
$342K Sell
4,736
-1,789
-27% -$126K 0.05% 311
2018
Q1
$491K Sell
6,525
-207
-3% -$16.5K 0.07% 241
2017
Q4
$496K Buy
6,732
+574
+9% +$43.6K 0.08% 218
2017
Q3
$506K Sell
6,158
-1,475
-19% -$113K 0.08% 237
2017
Q2
$532K Sell
7,633
-2,564
-25% -$171K 0.09% 207
2017
Q1
$681K Sell
10,197
-17,984
-64% -$1.26M 0.12% 147
2016
Q4
$2.07M Buy
28,181
+12,936
+85% +$962K 0.41% 45
2016
Q3
$1.21M Buy
15,245
+4,010
+36% +$326K 0.24% 79
2016
Q2
$937K Buy
11,235
+2,138
+24% +$190K 0.19% 100
2016
Q1
$841K Sell
9,097
-5,648
-38% -$509K 0.19% 93
2015
Q4
$1.49M Buy
14,745
+3,296
+29% +$343K 0.33% 45
2015
Q3
$1.06M Buy
11,449
+185
+2% +$20.5K 0.27% 52
2015
Q2
$1.25M Buy
11,264
+953
+9% +$104K 0.3% 63
2015
Q1
$953K Buy
10,311
+1,811
+21% +$184K 0.21% 71
2014
Q4
$801K Sell
8,500
-220
-3% -$22.8K 0.2% 81
2014
Q3
$864K Buy
8,720
+370
+4% +$36.2K 0.23% 62
2014
Q2
$692K Buy
8,350
+3,927
+89% +$306K 0.19% 86
2014
Q1
$271K Buy
4,423
+473
+12% +$37.1K 0.09% 183
2013
Q4
$297K Sell
3,950
-67
-2% -$4.67K 0.1% 165
2013
Q3
$252K Sell
4,017
-307
-7% -$18.3K 0.1% 180
2013
Q2
$223K Buy
+4,324
New +$225K 0.1% 194

Other funds holding GILD

Prospera Financial Services's GILD Position: Q2 2026 in Review

Prospera Financial Services reduced its Gilead Sciences (GILD) stake by 1.6% in Q2 2026, selling an estimated $150K and leaving 71,841 shares worth $9.08M. The position accounts for 0.13% of the portfolio, ranked #170.

Prospera Financial Services first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.9M in Q1 2025. 588 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Prospera Financial Services held 71,841 shares of Gilead Sciences worth $9.08M as of Q2 2026.
  • Prospera Financial Services sold 1,136 Gilead Sciences shares in Q2 2026, an estimated $150K.
  • Gilead Sciences made up 0.13% of Prospera Financial Services's portfolio in Q2 2026, its #170 holding.
  • Prospera Financial Services first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Prospera Financial Services's Gilead Sciences position peaked at $13.9M in Q1 2025.
  • 588 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.